BSE Live
Dec 05, 16:01Prev. Close
3054.45
Open Price
3053.45
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 05, 15:53Prev. Close
3054.10
Open Price
3040.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
3029.60 (53)
| Profit & Loss account of Dr Lal PathLabs (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 636.61 | 540.79 | 421.17 | 319.13 | 224.66 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 636.61 | 540.79 | 421.17 | 319.13 | 224.66 | |
| Total Operating Revenues | 636.61 | 540.79 | 421.17 | 319.13 | 224.66 | |
| Other Income | 12.64 | 8.72 | 2.89 | 1.97 | 2.26 | |
| Total Revenue | 649.25 | 549.51 | 424.06 | 321.10 | 226.92 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating And Direct Expenses | 134.76 | 114.47 | 91.81 | 71.80 | 58.70 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Employee Benefit Expenses | 131.21 | 99.32 | 91.10 | 51.59 | 36.12 | |
| Finance Costs | 0.39 | 0.24 | 0.36 | 2.51 | 0.59 | |
| Depreciation And Amortisation Expenses | 31.84 | 31.45 | 18.32 | 18.10 | 12.04 | |
| Other Expenses | 219.76 | 192.69 | 151.76 | 116.36 | 76.58 | |
| Total Expenses | 517.97 | 438.17 | 353.34 | 260.36 | 184.04 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 131.28 | 111.34 | 70.72 | 60.74 | 42.88 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 131.28 | 111.34 | 70.72 | 60.74 | 42.88 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 48.92 | 44.40 | 31.85 | 20.13 | 13.90 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | -5.61 | -7.02 | -10.00 | -0.40 | 0.56 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 43.31 | 37.39 | 21.85 | 19.73 | 14.45 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 87.97 | 73.95 | 48.88 | 41.01 | 28.43 | |
| Profit/Loss From Continuing Operations | 87.97 | 73.95 | 48.88 | 41.01 | 28.43 | |
| Profit/Loss For The Period | 87.97 | 73.95 | 48.88 | 41.01 | 28.43 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 15.37 | 13.16 | 8.55 | 6.69 | 4.57 | |
| Diluted EPS (Rs.) | 10.71 | 9.05 | 6.02 | 5.09 | 3.47 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 8.38 | 5.71 | 5.18 | 8.62 | 5.57 | |
| Tax On Dividend | 2.54 | 1.45 | 1.32 | 2.09 | 1.35 | |
| Equity Dividend Rate (%) | 15.00 | 11.00 | 154.00 | 257.00 | 164.00 |
05.12.2025
10.11.2025
Dr Lal PathLab Standalone September 2025 Net Sales at Rs 699.60 crore, up 19.82% Y-o-Y
31.10.2025
Dr Lal PathLab Consolidated September 2025 Net Sales at Rs 730.60 crore, up 10.66% Y-o-Y
01.08.2025
Dr Lal PathLab Consolidated June 2025 Net Sales at Rs 669.80 crore, up 11.28% Y-o-Y
10.11.2025
Dr Lal PathLab Standalone September 2025 Net Sales at Rs 699.60 crore, up 19.82% Y-o-Y
31.10.2025
Dr Lal PathLab Consolidated September 2025 Net Sales at Rs 730.60 crore, up 10.66% Y-o-Y
01.08.2025
Dr Lal PathLab Consolidated June 2025 Net Sales at Rs 669.80 crore, up 11.28% Y-o-Y
31.07.2025
Dr Lal PathLab Standalone June 2025 Net Sales at Rs 640.70 crore, up 19.87% Y-o-Y
06.10.2021
Dr. Lal PathLabs Q2 PAT seen up 28.4% YoY to Rs 112 cr: Prabhudas Lilladher
18.01.2021
Dr. Lal PathLabs Q3 PAT seen up 27.4% YoY to Rs. 54.1 cr: Prabhudas Lilladher
11.10.2019
Dr Lal Pathlabs Q2 PAT seen up 48.8% YoY to Rs. 84.8 cr: Kotak
15.07.2019
Dr Lal Pathlabs Q1 PAT seen up 17.6% YoY to Rs. 58.1 cr: Kotak